基本信息
views: 130
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Approach
The group studies lymphoid neoplasms such as chronic lymphocytic leukaemia or mantle cell lymphoma from the perspective of epigenetics, which is the science that analyses the way in which gene expression is regulated.
Its aim is to discover and evaluate the keys to the transcriptional alterations found in samples from patients with lymphoid cancer. To achieve this, the group studies different epigenetic markers such as DNA methylation, histone modifications, chromatin accessibility, and 3D genome structure.
Impact
The group’s research has resulted in different findings, such as: knowledge of how lymphoid neoplasms maintain an epigenetic signature from their cell of origin; that the activity of regulatory sites at a distance from the genes, so-called enhancers, are deregulated by epigenetic alterations and mutations; and that certain transcription factors appear to be the main elements responsible for altering the activity of the regulatory sites.
Apart from helping to understand how lymphoid neoplasms function, these studies have enabled the group to better calculate the clinical outcome of patients and identify new therapeutic targets.
The group studies lymphoid neoplasms such as chronic lymphocytic leukaemia or mantle cell lymphoma from the perspective of epigenetics, which is the science that analyses the way in which gene expression is regulated.
Its aim is to discover and evaluate the keys to the transcriptional alterations found in samples from patients with lymphoid cancer. To achieve this, the group studies different epigenetic markers such as DNA methylation, histone modifications, chromatin accessibility, and 3D genome structure.
Impact
The group’s research has resulted in different findings, such as: knowledge of how lymphoid neoplasms maintain an epigenetic signature from their cell of origin; that the activity of regulatory sites at a distance from the genes, so-called enhancers, are deregulated by epigenetic alterations and mutations; and that certain transcription factors appear to be the main elements responsible for altering the activity of the regulatory sites.
Apart from helping to understand how lymphoid neoplasms function, these studies have enabled the group to better calculate the clinical outcome of patients and identify new therapeutic targets.
Research Interests
Papers共 307 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
BRITISH JOURNAL OF HAEMATOLOGYno. 1 (2024): 160-170
Elina Alaterre,Sara Ovejero,Caroline Bret,Laure Dutrieux, Dassou Sika, Raul Fernandez Perez,Marion Espéli,Thierry Fest,Michel Cogné,José Ignacio Martin-Subero,Pierre Milpied,Giacomo Cavalli,
HEMASPHEREno. 1 (2024): e30-e30
IMMUNITYno. 2 (2024): 379-399.e18
Helen Parker,Amatta Mirandari,Carolina Jaramillo Oquendo,Martí Duran-Ferrer, Benjamin Stevens, Lara Buermann,Harindra E. Amarasinghe,Jaya Thomas,Latha Kadalayil,Louise Carr, Shama Syeda, Methusha Sakthipakan,
medrxiv(2024)
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASEno. 1 (2024): 371-396
Bloodno. 19 (2024): 1953-1964
Cancer Researchno. 6_Supplement (2024): 4300-4300
Load More
Author Statistics
#Papers: 243
#Citation: 12811
H-Index: 59
G-Index: 109
Sociability: 8
Diversity: 3
Activity: 102
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn